Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Scotia drug shows excellent activity in cancer patients with cachexia

Dec. 11, 1996

Cholesterol-lowering statin approved in first markets

Dec. 11, 1996

New IGF-I variant disclosed by P&U

Dec. 11, 1996

FemPatch approved for marketing in U.S.

Dec. 10, 1996

Benzothiophene compounds for women's health disclosed by Lilly

Dec. 10, 1996

GRF analogs under study at Tulane University

Dec. 10, 1996

New calcimimetic agents from ZymoGenetics

Dec. 9, 1996

Etex signs marketing agreement for bone substitute

Dec. 6, 1996

Successful pivotal Mexican trial for oral impotency therapy

Dec. 6, 1996

Houghten's lead CRA safe in diabetics

Dec. 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Dual-targeting, rapamycin-enhanced CAR T for multiple myeloma
BioWorld Science
Umoja Biopharma Inc. performed preclinical studies to evaluate the antitumor activity of UB-VV500, an off-the-shell lentiviral vector CAR T-cell product. It is...